RA Capital Management L.P. Buys Shares of 217,000 Acadia Healthcare Company, Inc. $ACHC

Key Points

• RA Capital Management L.P. has acquired 217,000 shares of Acadia Healthcare, valued at approximately $6,579,000, during the first quarter, representing a 0.24% stake in the company.
• Acadia Healthcare reported earnings per share (EPS) of $0.83 for the last quarter, exceeding analyst expectations of $0.71, with quarterly revenue up by 9.2% year-over-year.
• Analysts have mixed ratings on Acadia Healthcare, with nine investment firms rating it as 'Buy', while price targets have varied from $28.00 to $45.00.

RA Capital Management L.P. bought a new stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 217,000 shares of the company's stock, valued at approximately $6,579,000. RA Capital Management L.P. owned 0.24% of Acadia Healthcare at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. UMB Bank n.a. raised its position in shares of Acadia Healthcare by 149.5% during the first quarter. UMB Bank n.a. now owns 1,260 shares of the company's stock worth $38,000 after purchasing an additional 755 shares during the period. Caitong International Asset Management Co. Ltd raised its position in shares of Acadia Healthcare by 11,218.2% during the first quarter. Caitong International Asset Management Co. Ltd now owns 1,245 shares of the company's stock worth $38,000 after purchasing an additional 1,234 shares during the period. State of Wyoming acquired a new stake in shares of Acadia Healthcare during the fourth quarter worth about $56,000. Covestor Ltd raised its position in shares of Acadia Healthcare by 56.0% during the first quarter. Covestor Ltd now owns 2,262 shares of the company's stock worth $69,000 after purchasing an additional 812 shares during the period. Finally, Aquatic Capital Management LLC acquired a new stake in shares of Acadia Healthcare during the fourth quarter worth about $97,000.

Acadia Healthcare Stock Up 1.5%

NASDAQ:ACHC opened at $22.96 on Tuesday. The company has a debt-to-equity ratio of 0.73, a quick ratio of 1.32 and a current ratio of 1.32. The company has a market cap of $2.12 billion, a PE ratio of 15.21, a PEG ratio of 4.52 and a beta of 0.89. Acadia Healthcare Company, Inc. has a 52-week low of $17.13 and a 52-week high of $82.40. The stock has a 50-day simple moving average of $22.06 and a 200 day simple moving average of $25.19.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last posted its quarterly earnings data on Tuesday, August 5th. The company reported $0.83 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.71 by $0.12. The business had revenue of $869.23 million during the quarter, compared to the consensus estimate of $839.59 million. Acadia Healthcare had a return on equity of 8.34% and a net margin of 4.31%.Acadia Healthcare's quarterly revenue was up 9.2% on a year-over-year basis. During the same period last year, the company earned $0.91 earnings per share. Acadia Healthcare has set its FY 2025 guidance at 2.450-2.65 EPS. On average, sell-side analysts expect that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current fiscal year.

Analyst Ratings Changes

ACHC has been the topic of a number of research analyst reports. Wall Street Zen raised Acadia Healthcare from a "sell" rating to a "hold" rating in a research report on Sunday, August 3rd. Cowen reaffirmed a "buy" rating on shares of Acadia Healthcare in a research report on Thursday, August 7th. UBS Group dropped their price target on Acadia Healthcare from $45.00 to $31.00 and set a "buy" rating on the stock in a research report on Thursday, August 7th. Stephens upgraded Acadia Healthcare to a "hold" rating in a report on Monday, June 2nd. Finally, Royal Bank Of Canada decreased their price objective on Acadia Healthcare from $43.00 to $28.00 and set an "outperform" rating for the company in a report on Wednesday, August 13th. Nine investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the company's stock. According to MarketBeat.com, Acadia Healthcare currently has a consensus rating of "Moderate Buy" and a consensus price target of $40.77.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.